You are here:
NICE
NICE Guidance
Conditions and diseases
Infections
Hepatitis
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
Technology appraisal guidance
Reference number:
TA106
Published:
23 August 2006
Last updated:
27 November 2013
Guidance
Tools and resources
Information for the public
History
Download guidance (PDF)
Overview
1 Guidance
2 Clinical need and practice
3 The technology
4 Evidence and interpretation
5 Implementation
6 Recommendations for further research
7 Related guidance
8 Review of guidance
Appendix A. Appraisal Committee members and NICE project team
Appendix B. Sources of evidence considered by the Committee
Appendix C. Detail on criteria for audit of the use of peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
Changes after publication
About this guidance
Changes after publication
March 2012: minor maintenance.
November 2013: partial update.
Next page
About this guidance
Previous page
Appendix C. Detail on criteria for audit of the use of peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C